Overview
INJ and PGOLD rarely move in perfect sync. Today’s print ($5.10/$4,039.66) and 24h leaders (Injective) help frame which side currently carries relative strength.
Quick winners
Full comparison
| Metric | INJ | PGOLD |
|---|---|---|
| Price | $5.10 | $4,039.66 |
| Market Cap | $490.41M | $78.79M |
| FDV | — | — |
| Volume 24h | $2.58M | $2.17 |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 99.00 | 294.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +5.97% | +3.64% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | INJ | PGOLD |
|---|---|---|
| 1H | — | — |
| 24H | +3.59% | -0.10% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | INJ | PGOLD |
|---|---|---|
| RSI | 49.29 | 49.02 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 0.29 | 67.35 |
| ADX | 12.19 | 21.33 |
| Support | 4.91 | 1,827.82 |
| Resistance | 5.47 | 1,960.30 |
| Trend | neutral | bearish |
| Momentum | — | 59.00 |
| Signal | neutral | neutral |
Automatic technical analysis
Automated technical notes for this pair highlight neutral conditions on INJ and bearish on PGOLD. Volatility differences can amplify short-term gaps.
Fundamentals
| Metric | INJ | PGOLD |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | 0.00 | — |
| Github activity | 118.00 | — |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
Injective
Pleasing Gold
Pros and cons
Pros of Injective
- Market-cap scale on Injective may dampen some idiosyncratic shocks versus smaller peers.
- INJ often anchors narratives that attract sustained media and analyst coverage.
- Higher ranking for Injective can translate into tighter spreads on major venues.
Cons of Injective
- Data gaps in niche fundamentals still apply — absence of a field is not confirmation.
- Indicator stacks on Injective may stay stretched longer than expected in strong trends.
- Large-cap status for Injective can mean slower percentage upside versus high-beta alternatives.
Pros of Pleasing Gold
- If technical momentum aligns, Pleasing Gold may outperform on medium-term windows.
- PEPS tracking for Pleasing Gold still includes AI score and level context for monitoring.
- Narrative optionality around Pleasing Gold can reprice quickly when catalysts appear.
Cons of Pleasing Gold
- Higher volatility on PGOLD cuts both ways and demands stricter risk limits.
- Weaker market-cap standing may leave Pleasing Gold more exposed to liquidity droughts.
- Relative underperformance versus Injective can persist through entire market regimes.
Which looks stronger right now?
Across winners above, no single coin dominates every column. Prefer scenarios: trend continuation favors the side with aligned momentum; mean-reversion favors the side stretched on RSI.
AI summary
This AI-assisted summary starts from live PEPS fields. Injective holds market-cap $490.41M and rank #99; Pleasing Gold shows $78.79M and #294. Where liquidity and flow matter, watch Injective. Where durability matters, watch Injective. AI composite scores (48.70/58.20) compress those tensions into a single lens. In probabilistic terms, the side winning more columns may have a nearer-term edge, but tails remain fat. Revisit after the next hourly refresh.
FAQ
Which is better, Injective or Pleasing Gold?
“Better” depends on horizon and risk. Injective leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, INJ or PGOLD?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both Injective and Pleasing Gold.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Injective currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.